A head-to-head guide to superselective embolization-chemotherapy vs. percutaneous ablation: lesion type, sessions, anesthesia, repeatability and documentation.
2026-11-05 08:24:30
A plain-language guide to single-needle NanoKnife ablation: percutaneous access, local anesthesia, CT and ultrasound guidance, and same-session biopsy and pain control.
2026-11-04 07:42:53
Four documented minimally invasive cancer cases ranked by proof value: dated imaging, pathology, recovery records and follow-up plans from Guangzhou Fuda Cancer Hospital.
2026-10-28 05:19:25
A compliance checklist for minimally invasive cancer treatment records: anonymised baseline, pathology, MDT notes, procedure records, dated imaging comparisons, discharge and follow-up.
2026-10-24 07:26:59
Five anonymized case profiles show how to evaluate a Cancer Treatment Hospital's interventional oncology depth, plus the imaging, MDT and follow-up documents to request.
2026-10-23 05:21:26
How a 7 cm post-Whipple recurrence encasing the celiac trunk was treated with MDT review, CT plus ultrasound guidance, single-needle electric-field ablation and concurrent biopsy.
2026-10-20 07:15:39
A compliance guide to cross-border cancer care records: how published cases are anonymized, and how international patients request imaging comparison reports, procedure records, discharge and follow-up plans, and nursing records from Fuda Cancer Hospital.
2026-10-19 07:12:23
Compare cryoablation, Gamma Knife and single-needle S-IRE by metastatic site: accessibility, concurrent biopsy, anesthesia, recovery and systemic-therapy fit.
2026-10-16 07:12:59
How single-needle bipolar nanoKnife (S-IRE) ablation is performed under CT + US guidance and local anaesthesia — electrode geometry, concurrent biopsy and celiac plexus block, and how technical success is documented.
2026-10-12 05:18:58
A practical FAQ on long-term follow-up after minimally invasive cancer treatment — documented rehabilitation stages, imaging and pathology deliverables, scope boundaries, and referral partnership practices at Guangzhou Fuda Cancer Hospital.
2026-10-08 05:16:56
FAQ for international patients at Fuda Cancer Hospital: how long-term follow-up is scheduled, which records to request, and how cross-border continuity is handled.
2026-10-07 05:32:50
A shortlist of four image-guided interventional options for recurrent or metastatic cancer, with the documented inclusion rationale and deliverables for each approach.
2026-10-04 06:16:26
Ranked: seven documented capabilities that define a strong interventional oncology cancer treatment hospital, from MDT assessment to S-IRE ablation, HAIC and cross-border care.
2026-10-03 05:17:13
A 17 cm Ewing sarcoma lung metastasis was confused with small cell lung cancer morphology. See how MDT-led interventional embolization-chemotherapy reduced it to about 5 cm.
2026-09-30 05:16:26
A documented case: a 17 cm Ewing sarcoma lung metastasis in a young patient from Lebanon was treated without surgery in Guangzhou with staged superselective interventional embolization-chemotherapy, reducing the tumor to about 5 cm.
2026-09-29 05:18:26
A case-based comparison of ablation, superselective embolization-chemotherapy and HAIC: which lesion, anatomy and anesthesia constraints point to each minimally invasive route.
2026-09-26 05:18:04
Compare interventional oncology, systemic therapy and combined MDT care models, with documented cases from Fuda Cancer Hospital in Guangzhou, China.
2026-09-25 06:00:42
Compare minimally invasive cancer treatment options - cryoablation, NanoKnife IRE, vascular intervention and seed implantation - and learn how to evaluate a provider.
2026-09-22 15:16:33
A practical guide to minimally invasive cancer treatment: cryoablation, NanoKnife (IRE), vascular interventional oncology, patient selection, provider evaluation, and next steps.
2026-09-22 15:16:24
Minimally invasive cancer treatment explained: cryoablation, NanoKnife IRE, interventional oncology, and how providers plan non-surgical care for complex tumors.
2026-09-22 15:16:13